HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jorge E Cortes Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

11/2022A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase.
11/2022Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option.
6/2022Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis.
1/2022Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial.
12/2021Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias.
11/2021A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
7/2021Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trial.
6/2021Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapy.
1/2021The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes.
1/2021Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jorge E Cortes Research Topics

Disease

121BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2022 - 07/2002
85Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2021 - 06/2002
50Leukemia
12/2021 - 02/2002
43Philadelphia Chromosome
12/2021 - 07/2002
38Neoplasms (Cancer)
11/2022 - 07/2002
28Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2021 - 06/2002
25Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 07/2002
19Blast Crisis (Blast Phase)
12/2021 - 03/2006
16Hematologic Neoplasms (Hematological Malignancy)
09/2020 - 07/2002
13Exanthema (Rash)
06/2022 - 03/2003
11Primary Myelofibrosis (Myelosclerosis)
12/2020 - 05/2006
10Thrombocytopenia (Thrombopenia)
01/2021 - 09/2002
10Diarrhea
12/2018 - 03/2003
9Myeloid Leukemia (Leukemia, Myelocytic)
01/2021 - 06/2002
9Disease Progression
10/2020 - 01/2007
8Neutropenia
01/2021 - 05/2006
8Fatigue
01/2021 - 08/2003
7Nausea
01/2019 - 09/2003
7Pleural Effusion (Pleural Effusions)
01/2019 - 06/2005
6Anemia
10/2019 - 06/2002
6Residual Neoplasm
01/2018 - 12/2014
6Chromosome Aberrations (Chromosome Abnormalities)
01/2018 - 04/2004
5Hypertension (High Blood Pressure)
06/2021 - 01/2011
5Vomiting
10/2014 - 09/2003
4Pancreatitis
12/2019 - 11/2012
4Fever (Fevers)
01/2019 - 01/2008
4Pneumonia (Pneumonitis)
01/2019 - 10/2013
4Systemic Mastocytosis
01/2018 - 01/2007
4Polycythemia Vera
01/2017 - 06/2008
4Edema (Dropsy)
10/2014 - 02/2012
3Febrile Neutropenia
10/2019 - 01/2018
3Fibrosis (Cirrhosis)
10/2018 - 07/2015
3Cytopenia
10/2018 - 05/2006
3Hyperbilirubinemia
11/2017 - 03/2003
3Essential Thrombocythemia
01/2017 - 03/2011
3Hypoxia (Hypoxemia)
04/2016 - 02/2014
3Atrial Fibrillation
01/2016 - 06/2005
3Pathologic Complete Response
12/2015 - 06/2002
3Acute Promyelocytic Leukemia
11/2015 - 06/2002
3Splenomegaly
08/2015 - 10/2004
3Lymphoma (Lymphomas)
07/2015 - 01/2011
3Pain (Aches)
10/2014 - 08/2003
2Breast Neoplasms (Breast Cancer)
06/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

77Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 07/2002
63Tyrosine Kinase InhibitorsIBA
11/2022 - 09/2003
40Cytarabine (Cytosar-U)FDA LinkGeneric
07/2021 - 04/2002
35Dasatinib (BMS 354825)FDA Link
12/2021 - 05/2008
23bosutinibIBA
06/2022 - 05/2011
19Phosphotransferases (Kinase)IBA
12/2020 - 11/2005
15nilotinibFDA Link
12/2021 - 01/2010
15Pharmaceutical PreparationsIBA
01/2021 - 08/2003
13Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
09/2019 - 06/2002
11glasdegibIBA
07/2021 - 08/2015
10bcr-abl Fusion ProteinsIBA
01/2020 - 07/2002
9ponatinibIBA
01/2019 - 11/2012
8Azacitidine (5 Azacytidine)FDA Link
11/2021 - 01/2015
8Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2003
8fludarabineIBA
01/2018 - 04/2002
7Daunorubicin (Cerubidine)FDA LinkGeneric
01/2021 - 05/2014
7Gemtuzumab (Mylotarg)FDA Link
10/2020 - 06/2002
6LigandsIBA
11/2021 - 01/2011
6Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021 - 10/2013
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 04/2002
6quizartinibIBA
01/2021 - 10/2013
6CPX-351IBA
01/2021 - 05/2014
6Sorafenib (BAY 43-9006)FDA Link
11/2020 - 04/2010
5Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2015
5Core Binding Factors (Core-Binding Factor)IBA
01/2021 - 07/2009
5Transaminases (Aminotransferases)IBA
01/2020 - 01/2008
5ruxolitinibIBA
01/2020 - 08/2012
5DecitabineFDA Link
01/2020 - 04/2013
5Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017 - 08/2003
5troxacitabineIBA
12/2003 - 02/2002
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2016
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 01/2016
4Biological ProductsIBA
12/2020 - 07/2002
4Lipase (Acid Lipase)FDA Link
12/2019 - 11/2012
4fms-Like Tyrosine Kinase 3IBA
10/2019 - 01/2011
4Clofarabine (Clolar)FDA Link
01/2018 - 06/2010
4tipifarnib (R115777)IBA
01/2008 - 07/2002
3Drug CombinationsIBA
01/2021 - 05/2009
3InterferonsIBA
01/2021 - 01/2017
3Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2021 - 12/2012
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2018 - 10/2014
3Alanine Transaminase (SGPT)IBA
12/2018 - 10/2014
3Methotrexate (Mexate)FDA LinkGeneric
02/2016 - 04/2015
3HomoharringtonineIBA
05/2015 - 10/2013
3DNA (Deoxyribonucleic Acid)IBA
03/2014 - 12/2003
3Interferon-alpha (Interferon Alfa)IBA
10/2004 - 07/2002
3Farnesyltranstransferase (Farnesyltransferase)IBA
12/2003 - 07/2002
2venetoclaxIBA
01/2021 - 01/2020
2Lenalidomide (CC 5013)FDA Link
01/2021 - 01/2015

Therapy/Procedure

110Therapeutics
11/2022 - 06/2002
34Drug Therapy (Chemotherapy)
05/2021 - 09/2010
8Stem Cell Transplantation
09/2019 - 09/2002
7Drug Tapering
12/2021 - 04/2004
5Aftercare (After-Treatment)
06/2021 - 02/2003
5Salvage Therapy
01/2021 - 10/2013
5Induction Chemotherapy
11/2019 - 10/2013
2Hematopoietic Stem Cell Transplantation
01/2021 - 10/2020